CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Services-Commercial Physical & Biological Research · Services-Commercial Physical & Biological Research · NYSE
$291.76
+3.34%
Investru Score
42.0 / 100
Weak
Why is CRL moving?
CRL is up 3.34% today, in line with its broader uptrend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
CRL’s Investru Score changed +0.2 points recently. Want to know exactly what changed and why? That’s a Pro feature →
Score breakdown
- Financial Quality
- 48
- Growth
- 27
- Profitability
- 28
- Balance Sheet
- 35
- Valuation
- 41
- Momentum
- 89
Score history
+0.2 over the last 2 days, driven mainly by momentum (+2).
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- Data unavailable
- ROE
- -4.6%
- FCF Margin
- 12.9%
- Free Cash Flow (TTM)
- $0.5B
- Earnings Quality (OCF ÷ Net Income)
- -5.1x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 158.8x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 3.6x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 3.6%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $-0.03
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-27Filed 2026-08-05
- 10-Q · Q1 FY26 · period ended 2026-03-28Filed 2026-05-07
- 10-K · FY25 · period ended 2025-12-27Filed 2026-02-18
- 10-Q · Q3 FY25 · period ended 2025-09-27Filed 2025-11-05
- 10-Q · Q2 FY25 · period ended 2025-06-28Filed 2025-08-06
- 10-K · FY24 · period ended 2024-12-28Filed 2025-02-19
- 10-K · FY23 · period ended 2023-12-30Filed 2024-02-14
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-22
- 10-K · FY21 · period ended 2021-12-25Filed 2022-02-16
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $14.4B · 52-week range $144.26–$303.31 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2018-05-10
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze CRL with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.